Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Semaglutide VS Liraglutide: Which Is Better For Weight LossBy: Biochempeg Scientific Inc. Domenica M. Rubino, M.D., from the Washington Center for Weight Management and Research in Arlington, Virginia, and colleagues compared the efficacy and adverse event profiles of once-weekly subcutaneous semaglutide (126 patients) versus once-daily subcutaneous liraglutide (127 patients) or placebo (85 patients) in people with overweight or obesity also undertaking diet and physical activity and followed for 68 weeks. The researchers found that participants had significantly greater odds of achieving ≥10 percent, ≥15 percent, and ≥20 percent weight loss with semaglutide versus liraglutide (odds ratios, 6.3, 7.9, and 8.2, respectively) "Whether semaglutide could be beneficial in preventing progression of cardiometabolic disease will be evaluated in the SELECT trial," the authors write. Several authors disclosed financial ties to pharmaceutical companies, including Novo Nordisk, which manufactures semaglutide and funded the trial. As a professional PEG supplier, Biopharma PEG (https://www.biochempeg.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|